Gamma Knife radiosurgery for intracranial metastatic melanoma: an analysis of survival and prognostic factors.
Objective of this study was to evaluate retrospectively the effectiveness of Gamma Knife radiosurgery for intracranial metastatic melanoma and to identify prognostic factors related to survival. Twenty-six patients with intracranial metastases (72 lesions) from melanoma underwent Gamma Knife radiosurgery. In 14 patients (54%) whole-brain radiotherapy (WBRT) was performed as part of the initial treatment, and in 12 patients (38%) immunotherapy and/or chemotherapy was given after Gamma Knife radiosurgery. The median tumor volume for Gamma Knife radiosurgery treated lesions was 1.72 cm3. The median prescribed radiation dose was 18 Gy (range 8-22 Gy) typically prescribed to the isodose at the tumor margin. Univariate and multivariate analyses were used to determine significant prognostic factors affecting survival. Overall median survival was 6 months after Gamma Knife radiosurgery, and 1-year survival was 25%. The median survival from the onset of brain metastases was 9 months and from the original diagnosis of melanoma was 50 months (range 4-160 months). There were no major acute or late GKS complications. In univariate testing, the Karnofsky score equal to or higher than 90% (P < 0.01, log-rank test), supratentorial localization (P < 0.001, log-rank test), intracranial tumor volume less than 1 cm3 (P < 0.02, log-rank test), and absence of neurological signs or symptoms before Gamma Knife radiosurgery (P < 0.003, log-rank test) were significant favorable factors for survival. In multivariate regression analyses, the most important predictors associated with increased survival were a KPS > or = 90 (P < 0.023), female sex (P < 0.004), supratentorial localization (P < 0.01), and absence of neurological symptoms (P < 0.008). Radiosurgery is a noninvasive, safe, and effective treatment option for patients with single or multiple intracranial metastases from melanoma. Female sex, Karnofsky score > or = 90, supratentorial localization and lack of symptoms before the Gamma Knife radiosurgery were good independent predictors of survival.
Koc
Mehmet
M
Division of Radiation Oncology, Arthur G. James Cancer Hospital and Research Institute, The Ohio State University, Columbus, OH, USA. mkoc@atauni.edu.tr
McGregor
John
J
Grecula
John
J
Bauer
Constance J
CJ
Gupta
Nilendu
N
Gahbauer
Reinhard A
RA
D000328:Adult; D000368:Aged; D001932:Brain Neoplasms / Q000401:mortality / Q000556:secondary* / Q000601:surgery* / Q000628:therapy; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008545:Melanoma / Q000401:mortality / Q000556:secondary* / Q000601:surgery* / Q000628:therapy; D008875:Middle Aged; D011379:Prognosis; D016634:Radiosurgery / Q000295:instrumentation*; D012189:Retrospective Studies; D012737:Sex Factors; D012878:Skin Neoplasms / Q000401:mortality / Q000473:pathology; D016019:Survival Analysis; D016896:Treatment Outcome
Neurosurgery. 1999 Jan;44(1):59-64; discussion 64-6
9894964
J Neurosurg. 2002 Dec;97(5 Suppl):494-8
12507084
Radiother Oncol. 2000 Nov;57(2):207-13
11054525
Cancer J Sci Am. 1996 Nov-Dec;2(6):335-42
9166554
J Neurosurg. 1998 Jan;88(1):11-20
9420067
Ann Neurol. 1980 Jun;7(6):529-41
7436358
Neurosurgery. 2000 Apr;46(4):860-6; discussion 866-7
10764259
Neurosurgery. 2000 Aug;47(2):268-79; discussion 279-81
10942000
Int J Cancer. 2000 Jun 20;90(3):157-62
10900428
Int J Radiat Oncol Biol Phys. 1996 Apr 1;35(1):27-35
8641923
Cancer. 1980 Feb 15;45(4):679-83
6766793
Radiother Oncol. 1992 Mar;23(3):185-91
1574597
J Neurosurg. 2002 Mar;96(3):544-51
11883840
Int J Radiat Oncol Biol Phys. 1998 Oct 1;42(3):581-9
9806518
J Natl Cancer Inst. 1995 Jan 4;87(1):34-40
7666461
Am J Surg. 1978 Jun;135(6):807-10
665907
Eur J Cancer. 1998 Jul;34(8):1187-92
9849477
J Clin Oncol. 1996 Apr;14(4):1085-92
8648361
Int J Radiat Oncol Biol Phys. 1994 Mar 1;28(4):797-802
8138431
Int J Radiat Oncol Biol Phys. 1997 Mar 1;37(4):745-51
9128946
Stereotact Funct Neurosurg. 2000;74(1):37-51
11124663
Cancer. 1985 Jul 1;56(1):1-9
4005778
Int J Radiat Oncol Biol Phys. 2002 Apr 1;52(5):1277-87
11955740
Cancer. 1997 Feb 1;79(3):551-7
9028367